31st Aug 2022 18:04
Ondine Biomedical Inc - Vancouver, Canada-based life sciences company focused on photodisinfection-based therapies - Publication by Toronto-based research firm Nature show a 90% decrease in viral infectivity of SARS-CoV-2 in patient samples following the use of Ondine's nasal antimicrobial photodynamic disinfection, with 70% of samples completely inactivated from a single 5-minute treatment.
"These promising results indicate the potential of photodisinfection as a novel tool against Covid-19 and should lead to further studies. This treatment, which has been clinically validated in high-risk surgical cases, leading to significantly reduced surgical site infections, could be important not only against Covid-19 but also other viral and bacterial transmissible diseases," the research team says.
Current stock price: 40.00 pence, up 3.9% on Wednesday
12-month change: down 31%
By Dayo Laniyan; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Ondine Biomed